JP3541007B2 - 両親媒性ポリサッカリド誘導体 - Google Patents

両親媒性ポリサッカリド誘導体 Download PDF

Info

Publication number
JP3541007B2
JP3541007B2 JP2000550884A JP2000550884A JP3541007B2 JP 3541007 B2 JP3541007 B2 JP 3541007B2 JP 2000550884 A JP2000550884 A JP 2000550884A JP 2000550884 A JP2000550884 A JP 2000550884A JP 3541007 B2 JP3541007 B2 JP 3541007B2
Authority
JP
Japan
Prior art keywords
heparin
acid
doca
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000550884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002516355A (ja
Inventor
ロー ビョン、ヨン
キュー イー、ヨン
Original Assignee
メディプレックス コーポレイション、コリア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019990014003A external-priority patent/KR100314496B1/ko
Application filed by メディプレックス コーポレイション、コリア filed Critical メディプレックス コーポレイション、コリア
Publication of JP2002516355A publication Critical patent/JP2002516355A/ja
Application granted granted Critical
Publication of JP3541007B2 publication Critical patent/JP3541007B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
JP2000550884A 1998-05-28 1999-05-14 両親媒性ポリサッカリド誘導体 Expired - Fee Related JP3541007B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
KR19980019469 1998-05-28
KR1019990014003A KR100314496B1 (ko) 1998-05-28 1999-04-20 항혈전성이 있는 헤파린 유도체, 그의 제조방법 및 용도
US1999/14003 1999-04-27
US09/300,173 1999-04-27
US1998/19469 1999-04-27
US09/300,173 US6245753B1 (en) 1998-05-28 1999-04-27 Amphiphilic polysaccharide derivatives
PCT/KR1999/000242 WO1999061481A1 (en) 1998-05-28 1999-05-14 Amphiphilic polysaccharide derivatives

Publications (2)

Publication Number Publication Date
JP2002516355A JP2002516355A (ja) 2002-06-04
JP3541007B2 true JP3541007B2 (ja) 2004-07-07

Family

ID=27349744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000550884A Expired - Fee Related JP3541007B2 (ja) 1998-05-28 1999-05-14 両親媒性ポリサッカリド誘導体

Country Status (5)

Country Link
JP (1) JP3541007B2 (de)
AU (1) AU3735899A (de)
DE (1) DE19981169B4 (de)
GB (1) GB2342357B (de)
WO (1) WO1999061481A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656922B2 (en) * 1998-05-28 2003-12-02 Mediplex Corporation, Korea Oral delivery of macromolecules
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
KR100378109B1 (ko) * 2000-10-24 2003-03-29 주식회사 메디프렉스 소수성 다중복합 헤파린 결합체, 그의 제조방법 및 용도
CN1531436A (zh) * 2001-05-09 2004-09-22 (株)美大富历寿 用于增强粘膜吸收的两亲肝素衍生物制剂
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
FR2864091B1 (fr) * 2003-12-19 2006-04-07 Ethypharm Sa Derive amphiphile d'heparine forme par couplage de l'heparine avec un acide biliaire
JP2008511651A (ja) 2004-08-30 2008-04-17 セオ ホン ユー 局所虚血モデルでの可溶化ｕｄｃａの神経保護効果
KR20070084211A (ko) 2004-10-15 2007-08-24 유서홍 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물
MX340993B (es) 2007-02-08 2016-08-02 Emisphere Tech Inc * Agentes de suministro de acido fenilalquilcarboxilico.
WO2009092151A1 (en) * 2007-12-05 2009-07-30 Xiao-Xia Zhu Amphiphilic polymers having a cholane core
JP5542687B2 (ja) * 2008-11-05 2014-07-09 国立大学法人 東京医科歯科大学 ヒアルロン酸誘導体、およびその医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891554A (en) * 1959-10-19 1962-03-14 Applic Chimiques D Etudes Et D Galenic suppository containing salts of heparin
US3482014A (en) * 1966-06-29 1969-12-02 Canada Packers Ltd Orally active heparin and method for making and using same
WO1995012620A1 (en) * 1993-11-01 1995-05-11 Alpha-Beta Technology, Inc. Derivatized polysaccharide bile acid sequestrant for reducing cholesterol
JPH07206903A (ja) * 1994-01-24 1995-08-08 Takeda Chem Ind Ltd 超分子構造型集合体

Also Published As

Publication number Publication date
GB0001794D0 (en) 2000-03-22
WO1999061481A1 (en) 1999-12-02
JP2002516355A (ja) 2002-06-04
GB2342357A (en) 2000-04-12
GB2342357B (en) 2002-03-27
DE19981169B4 (de) 2007-09-13
DE19981169T1 (de) 2000-11-16
AU3735899A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
US6245753B1 (en) Amphiphilic polysaccharide derivatives
US6656922B2 (en) Oral delivery of macromolecules
JP4332507B2 (ja) 医薬組成物
JP3398150B2 (ja) 新規接合体、その調製および使用ならびにその接合体を用いて調製された基体
DE69636813T2 (de) Heparine-proteine kovalente Konjugate, die eine Alpha-Carbonyl-Amin enthalten und Verfahren für deren Produktion
DE69819343T2 (de) Zusammensetzungen und ihre verwendung zur verhütung von verklebungen zwischen körpergewebe
AU692389B2 (en) Cyclodextrin compounds and methods of making and use thereof
JP3541007B2 (ja) 両親媒性ポリサッカリド誘導体
EP1794192B1 (de) Photovernetzbare polysaccharide, photovernetzte polysaccharidprodukte, deren verfahren zur herstellung und deren verwendung als medizinischen werkstoffe
JP3927118B2 (ja) 疎水性多重複合ヘパリン結合体、その製造方法及び用途
US5922690A (en) Dermatan disulfate, an inhibitor of thrombin generation and activation
JPH06506685A (ja) 新規な非抗凝固剤ヘパリン誘導体
WO2016168710A1 (en) Antithrombin-heparin compositions and methods
EP1899384A1 (de) Verfahren zur herstellung eines niedermolekularen heparins
EP0861082A1 (de) Therapie der gewebemembraninsuffizienz
JP5108519B2 (ja) ビオチニル化十六糖、この調製及び使用
WO1999026984A1 (fr) Modification de l'heparine de faible masse moleculaire et remede contre l'ulcere de la peau
AU2016274868B2 (en) Medical devices, systems, and methods utilizing antithrombin-heparin compositions
WO1994008595A1 (en) Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
EP4245764A1 (de) Neue kohlenhydratderivate als mimetika der antigene der blutgruppen a und b
Nechifor et al. Synthesis and pharmacological action of some cholestyramine analogs
CA2231989A1 (en) Therapy for tissue membrane insufficiency
Bolsinger Human platelet adhesion to heparinized silica surfaces

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20031128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040302

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040326

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080402

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090402

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100402

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100402

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110402

Year of fee payment: 7

LAPS Cancellation because of no payment of annual fees